Meet Assura: Our Net Cost Guarantee Pricing Solution
The cost of specialty medications continues to rise. With a growing pipeline of specialty drugs and newer therapies costing in excess of $100,000 for a single course of treatment, a handful of claims can significantly impact a plan’s financial performance and stability. At the same time, utilization of specialty drugs, particularly those treating cancer and autoimmune conditions, is also increasing.
In this climate, plans need a new approach and a PBM partner that is fully aligned with their goals and invested in helping them navigate this complex and uncertain environment.
